Axogen Sponsored REPOSE℠ Study Completes Pilot Phase Analysis
Press release content from Globe Newswire. The AP news staff was not involved in its creation. Axogen Sponsored REPOSE℠ Study Completes Pilot Phase Analysis Axogen, Inc.February 18, 2021 GMT ALACHUA, Fla., Feb. 18, 2021 (GLOBE NEWSWIRE) -- Axogen, Inc. (NASDAQ: AXGN), a global leader in developing and marketing innovative surgical solutions for damage or transection to peripheral nerves, today announced completion of pilot phase analysis for its REPOSE clinical study. Analysis of the REPOS...
Source: apnews.com